Delivery Order SPE2DB22D2007-SPE2DB24FJ4GY
Award Date
7/17/24
Potential Completion Date
7/18/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution services company. The contract is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a pharmaceutical product, with a potential value of $1,118.34 and a period of performance through January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,496.56, is for the provision of VISIPAQUE 270 MG/ML BOTTLE 150ML, a pharmaceutical product, to the agency. The contract has a firm fixed price pricing type and a completion date of May 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31,...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product, to support the Department of Defense (DoD) and other government agencies. The contract has a firm fixed price of $1,265.73 and a completion date of May 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,618.94 firm fixed-price contract is for the supply of VISIPAQUE 320 MG/ML infusion bottles. The contract has an ultimate completion date of December 4, 2024 and is not designated as a set-aside.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, to provide VISIPAQUE 320 MG/ML medical bottles to the U.S. government. The contract has a total ceiling value of $18,547.86 and was awarded on a firm fixed price basis to the prime contractor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00...
This is a $1,687.64 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of VISIPAQUE 320 MG/ML infusion bottles, with a completion date of July 23, 2024. The contract was awarded on July 22, 2024, and is a firm fixed-price agreement. The award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $2,109.55 contract is for the provision of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product, with a completion date of February 8, 2024.
Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and...
This federal contract award, with a ceiling value of $34,376.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a pharmaceutical product, with a performance period ending on April 16, 2024.
Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML. The contract has a ceiling value of $1,118.34 and is a Firm Fixed Price Delivery Order with a completion date of November 12, 2024. The contract is not designated as a set-aside.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML medical products. The $5,906.74 award has a completion date of February 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary...